期刊文献+

腹腔镜下可逆性子宫动脉阻断治疗剖宫产瘢痕部位妊娠的临床价值

Clinical value of laparoscopic reversible uterine artery occlusion in treatment of cesarean section scar pregnancy
原文传递
导出
摘要 目的探讨腹腔镜下可逆性子宫动脉阻断治疗剖宫产瘢痕部位妊娠的临床价值。方法选取蚌埠医学院第一附属医院2018年9月至2020年6月期间住院的112例诊断为Ⅱ型及Ⅲ型剖宫产瘢痕部位妊娠患者,按随机数字表法将患者分为对照组(n=58)与观察组(n=54),对照组采用子宫动脉栓塞术联合腹腔镜下妊娠物清除及子宫瘢痕修补术,观察组采用腹腔镜下可逆性子宫动脉阻断后进行妊娠物清除术及子宫瘢痕修补术,对比两组患者临床治疗效果。结果对照组术中出血量(21.26±9.64)ml,显著小于观察组(75.25±8.25)ml(P<0.05);观察组治疗成功率为98.15%(53/54),显著高于对照组86.21%(50/58)(P<0.05);观察组阴道流血时间(7.26±0.94)d、术后月经回潮时间(31.25±1.26)d、住院时间(3.14±0.25)d,均显著小于对照组[(9.54±0.86)、(47.25±2.15)、(9.26±0.94d)](P<0.05);术后24 hβ-hCG水平及β-hCG转阴时间观察组[(1015.11±325.05)IU/L、(14.25±3.21)d]显著小于对照组[(2654.25±284.25)IU/L、(27.16±5.14)d](P<0.05);两组患者治疗前改良SF-36量表评分对比差异无统计学意义(P>0.05),观察组治疗后改良SF-36量表评分(63.22±4.25)分显著高于对照组(55.25±3.83)分(P<0.05)。结论腹腔镜下可逆性子宫动脉阻断治疗剖宫产瘢痕部位妊娠疗效确切,患者β-hCG水平显著降低、生活质量显著改善。 Objective To explore the clinical value of laparoscopic reversible uterine artery occlusion in the treatment of cesarean section scar pregnancy.Methods A total of 112 patients who were hospitalized in our hospital from Sep.2018 to Jun.2020 in the First Affiliated Hospital of Bengbu Medical College and diagnosed with type II and type III cesarean section scars were selected.The patients were divided into groups according to the randomization method,the control group(n=58)and the study group(n=54).The control group used uterine artery embolization combined with laparoscopic removal of pregnancy and uterine scar repair,while the study group used laparoscopic reversible uterine artery occlusion,pregnancy removal surgery and uterine scar repair surgery.The clinical treatment effects of the two groups of patients were compared.Results The intraoperative blood loss of the control group(21.26±9.64)ml was significantly less than that of the study group(75.25±8.25)ml(P<0.05);the treatment success rate of the study group was 98.15%(53/54),which was significantly higher than the control group 86.21%(50/58)(P<0.05);the time of vaginal bleeding in the study group(7.26±0.94)d,postoperative menstrual regain time(31.25±1.26)d,and hospital stay(3.14±0.25)d were significantly less than those in the control group[(9.54±0.94)0.86d,(47.25±2.15)d,(9.26±0.94)d](P<0.05);24 hβ-hCG level andβ-hCG negative time study group[(1015.11±325.05)IU/L,(14.25±3.21)d]was significantly less than the control group[(2654.25±284.25)IU/L,(27.16±5.14)d](P<0.05);there was no difference in the scores of the modified SF-36 scale before treatment between the two groups(P>0.05).The modified SF-36 scale score(63.22±4.25)of the study group after treatment was significantly higher than that of the control group(55.25±3.83)(P<0.05).Conclusions Laparoscopic reversible uterine artery occlusion is effective in treating cesarean section scar pregnancy.After treatment,theβ-hCG level of the patient is significantly reduced and the quality of life is significantly improved.
作者 刘琼 林路 何玉 Liu Qiong;Lin Lu;He Yu(Department of Gynecology,First Affiliated Hospital of Bengbu Medical College,Bengbu 233004,China)
出处 《中华内分泌外科杂志》 CAS 2022年第6期689-692,共4页 Chinese Journal of Endocrine Surgery
关键词 腹腔镜 可逆性子宫动脉阻断 剖宫产瘢痕部位妊娠 妊娠物清除术 子宫瘢痕修补术 Laparoscopy Reversible uterine artery occlusion Cesarean scar pregnancy Removal of pregnancy Uterine scar repair
  • 相关文献

参考文献8

二级参考文献57

  • 1官泳松,刘源.经导管子宫动脉栓塞术临床应用进展[J].中国微创外科杂志,2005,5(3):172-174. 被引量:7
  • 2金力,范光升,郎景和.剖宫产术后瘢痕妊娠的早期诊断与治疗[J].生殖与避孕,2005,25(10):630-634. 被引量:243
  • 3Litwicka K, Greco E. Caesarean scar pregnancy: a review ofmanagement options[J]. Curr Opin Obstet Gynecol, 2013,25(6):456-461. DOI: 10.1097/GC0.0000000000000023.
  • 4Seow KM, Huang LW, Lin YH, et al. Caesarean scarpregnancy: issues in management[J]. Ultrasound ObstetGynecol, 2004, 23(3):247-253.
  • 5Fylstra DL. Ectopic pregnancy within a cesarean scar: a review[J]. Obstet Gynecol Surv, 2002, 57(8):537-543.
  • 6Vial Y, Petignat P, Hohlfeld P. Pregnancy in a cesarean scar[J]. Ultrasound Obstet Gynecol, 2000,16(6):592-593.
  • 7Liu S,Sun J, Cai B, et al. Management of Cesarean ScarPregnancy Using Ultrasound-Guided Dilation and Curettage[J]. J Minim Invasive Gynecol, 2016,23(5):707-711. DOI:10.1016/j.jmig.2016.01.012.
  • 8Wang M, Yang Z, Li Y,et al. Conservative management ofcesarean scar pregnancies: a prospective randomizedcontrolled trial at a single center[J]. Int J Clin Exp Med, 2015,8(10):18972-18980.
  • 9Yin XH, Yang SZ, Wang ZQ, et al. Injection of MTX for thetreatment of cesarean scar pregnancy: comparison betweendifferent methods[J]. Int J Clin Exp Med, 2014, 7(7):1867-1872.
  • 10Jurkovic D, Hillaby K, Woelfer B, et al. First-trimesterdiagnosis and management of pregnancies implanted into thelower uterine segment Cesarean section scar[J]. UltrasoundObstet Gynecol, 2003,21(3):220-227. DOI: 10.1002/uog.56.

共引文献814

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部